Publications by authors named "S M Oser"
This qualitative substudy sought to identify and understand the experiences of primary care patients with type 1 diabetes using the iLet Bionic Pancreas (Beta Bionics, Inc.) during the first clinical trial testing the automated insulin delivery (AID) system in the primary care setting. Participants in that clinical trial completed a brief semi-structured interview after the trial's completion, during which they were asked questions related to their perceptions of and experiences with using the iLet AID system.
View Article and Find Full Text PDFBackground: Older adults may be less comfortable with continuous glucose monitoring (CGM) technology or require additional education to support use. The Virtual Diabetes Specialty Clinic study provided the opportunity to understand glycemic outcomes and support needed for older versus younger adults living with diabetes and using CGM.
Methods: Prospective, virtual study of adults with type 1 diabetes (T1D, N = 160) or type 2 diabetes (T2D, N = 74) using basal-bolus insulin injections or insulin pump therapy.
Background: Continuous glucose monitoring (CGM) for patients with type 1 and type 2 diabetes is associated with improved clinical, behavioral, and psychosocial patient health outcomes and is part of the American Diabetes Association's Standards of Medical Care. CGM prescription often takes place in endocrinology practices, yet 50% of adults with type 1 diabetes and 90% of all people with type 2 diabetes receive their diabetes care in primary care settings. This study examined primary care clinicians' perceptions of barriers and resources needed to support CGM use in primary care.
View Article and Find Full Text PDFArticle Synopsis
- * Insulin icodec is a new once-weekly basal insulin that shows similar efficacy and safety to traditional daily insulin, potentially improving adherence.
- * The review suggests that insulin icodec can help overcome patient-clinician barriers related to diabetes management, with ongoing clinician support enhancing patient self-management.
Article Synopsis
- - The study focused on evaluating patient-reported outcomes (PROs) for adults with diabetes (234 participants) who accessed a virtual clinic model that included continuous glucose monitoring (CGM) support for 6 months.
- - After 6 months, participants reported reduced depression, diabetes distress, and hypoglycemic fears, and showed increased satisfaction and confidence in managing their diabetes, particularly regarding CGM.
- - The findings indicated that using virtual diabetes care led to significant improvements in both glycemic control and overall quality of life, particularly for those with type 1 diabetes who spent more time in their target glucose range.